can glp-1 cause headaches GLP-1s and Eye Health: What You Need to Know Long-Term Effects Of GLP-1 Medications:

Lilly is building a multi-engine growth machine: Alzheimer's Treatment Kisunla (Donanemab) - FDA-approved for early Alzheimer's, first proven to slow cognitive decline Represents a breakthrough in neurodegenerative disease treatment Oncology & Immunology Verzenio (breast cancer): $1.47B in Q3 2025 (+7% YoY) Jaypirca and Omvoh expanding in oncology and autoimmune markets Radiopharmaceutical investments through Point Biopharma ($1.4B acquisition) and Aktis Oncology partnership Pipeline Depth 40+ programs in Phase 2/3 across neuroscience, immunology, and cardiology Recent acquisitions: Scorpion Therapeutics, SiteOne Therapeutics, Adverum Biotechnologies Lilly isn't a one-trick pony

This is usually followed by an off-cycle period of at least the same duration to assess the results

1,067.00Current price is: 1,067.00

It does not change the active compound or the patient experience but may improve vial-to-vial consistency and extend stability